Bioactivity-guided evaluation of F7 fraction derived from Acalypha cuspidata on ovarian cancer models in vitro and in vivo
Herrera-Martínez Mayra, Hernández-Ramírez Verónica Ivonne, Hernández-Carlos Beatriz, Talamás-Rohana Patricia · 2026
Read Bioactivity-guided evaluation of F7 fraction derived from Acalypha cuspidata on ovarian cancer models in vitro and in vivo by Herrera-Martínez Mayra, Hernández-Ramírez Verónica Ivonne, Hernández-Carlos Beatriz, Talamás-Rohana Patricia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272508.txt.
Description
Mayra Herrera-Martínez and co-authors tested a plant fraction against ovarian cancer in a 2026 laboratory study. The fraction, called F7, came from an extract of Acalypha cuspidata, a plant studied for compounds that kill cancer cells. Earlier work pointed to this extract, so the team followed its activity step by step.
They split the extract into eleven fractions and tested each on SKOV-3 ovarian cancer cells. F7 killed cancer cells while sparing a non-cancer cell line and proving gentler on rat liver cells than a rival fraction. Treated cells showed clear signs of programmed cell death, with damaged mitochondria. In mice carrying human tumors, F7 slowed tumor growth compared with untreated controls.
Catalog record
| CREATOR | Herrera-Martínez Mayra, Hernández-Ramírez Verónica Ivonne, Hernández-Carlos Beatriz, Talamás-Rohana Patricia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |